Criteria | Dutra et al. 2017 [82] | Gupta SJ et al. 2014 [72] | Grimrad et al.2009 [68] | Khosropana et al.2015 [91] | Nemoto et al. 2018 [85] | Bhavsar et al. 2016 [77] | Pajnigara et al. 2017 [79] |
---|---|---|---|---|---|---|---|
Did the trial address a clearly focused issue? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Was the assignment of patients to treatments randomized? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were all of the patients who entered the trial properly accounted for at its conclusion? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were patients, health workers and study personnel ‘blind’ to treatment? | Can’t tella | Can’t tella | Yes | Yes | Yes | Yes | Yes |
Were the groups similar at the start of the trial | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Aside from the experimental intervention, were the groups treated equally? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
How large was the treatment effect? | Satisfactory | Satisfactory | Satisfactory | Satisfactory | Satisfactory | Satisfactory | Satisfactory |
How precise was the estimate of the treatment effect? | Acceptable | Acceptable | Acceptable | Accept-able | Acceptable | Acceptable | Acceptable |
Can the results be applied to the local population or in your contex | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were all clinically important outcomes considered? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Are the benefits worth the harms and costs? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |